TMDX Q3 2019 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M+78.4% YoY

Gross Profit

$4M58.5% margin

Operating Income

-$7M-100.5% margin

Net Income

-$8M-114.9% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+27.2%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$295,000

Balance Sheet

Total Assets

$113M

Total Liabilities

$49M

Stockholders' Equity

$63M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$4M	+78.4%
Gross Profit	$4M	$2M	+97.7%
Operating Income	-$7M	-$4M	-83.9%
Net Income	-$8M	-$5M	-62.2%

Revenue Segments

Ocs Heart Product

$4M52%

Ocs Lung Product

$2M29%

Ocs Liver Product

$1M19%

Geographic Segments

UNITED STATES

$4M67%

Other Countries

$2M26%

AUSTRALIA

$251,0004%

GERMANY

$194,0003%